AzTrials
AzTrials

ArthritisNCT05289544

Phone-Based Based Walk With Ease Program for Adults With Arthritis

A study testing Phone-Based Walk With Ease in people with Arthritis and Gout, run by University of South Carolina at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The objective of this study is to examine the short-term (6-weeks and 6 months) and long-term (1 year) effects of a phone-based version of Walk With Ease intervention. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Arthritis, Gout, Fibromyalgia
What is being tested?
Phone-Based Walk With Ease
Could I receive a placebo?
No, everyone receives an active treatment
How many people
267 participants
Where
1 siteUnited States
Study dates
1 Apr 2022to 10 Sep 2024
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • told by a doctor or other health professional that you have some form of arthritis, rheumatoid arthritis, gout, lupus, fibromyalgia
  • able to read and write in English
  • plan to live in the Columbia, SC region for next year
  • willing to be randomized to either group
  • complete all baseline measure

Who cannot join

  • contraindications to exercise (besides arthritis)
  • are pregnant, breastfeeding, or planning to become pregnant in the next year
  • have a serious cognitive impairment

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of South Carolina

    Columbia, South Carolina, 29208

Other trials in United States

About this study

Official title: Evaluating Alternative Delivery Models for Arthritis Self-management Interventions

The objective of this study is to examine the short-term (6-weeks and 6 months) and long-term (1 year) effects of a phone-based version of Walk With Ease intervention.

Read the detailed description

Participants will be randomized to either start the 6-week program immediately or after one year. Our Walk with Ease by Telephone (WWE-T) program is adapted from the original 6-week community-based group walking program developed by the Arthritis Foundation for adults with arthritis. The phone-based program will include 2 phone calls each week with a trained Walk With Ease Leader for 6 weeks. Assessments will be completed before at the start of the study, 6 weeks, 6 months and at 12 months.

Being tested
Phone-Based Walk With Ease
Keywords
Arthritis, Physical activity, Intervention
Medical subject headings
Arthritis, Gout, Fibromyalgia, Arthritis, Rheumatoid, Osteoarthritis, Lupus Erythematosus, Systemic, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Phone-Based Walk With EaseBehavioural

    6 week phone-delivered Walk With Ease Program

Study groups in NCT05289544
Study groupRoleWhat they receive
Phone-Based Walk With Ease ProgramExperimentalTelephone-based Walk With Ease Program adapted from the Arthritis Foundations program
Receives: Behavioral: Phone-Based Walk With Ease
Delayed Phone-Based Walk With Ease ProgramOtherTelephone-Based Walk With Ease Program starting after the 1 year assessment
Receives: Behavioral: Phone-Based Walk With Ease

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Pain

    Visual analog scale (0mm no/low pain to 100 mm high pain)

    Measured: Baseline to 6 weeks

  2. Change in Pain

    Visual analog scale (0mm no/low pain to 100 mm high pain)

    Measured: Baseline to 6 months

  3. Change in Pain

    Visual analog scale (0mm no/low pain to 100 mm high pain)

    Measured: Baseline to 12 months

  4. Change in Physical Function - Chair Stands

    repetitions completed during 30 second chair stand test

    Measured: Baseline to 6 weeks

  5. Change in Physical Function - Chair Stands

    repetitions completed during 30 second chair stand test

    Measured: Baseline to 6 months

  6. Change in Physical Function - Chair Stands

    repetitions completed during 30 second chair stand test

    Measured: Baseline to 12 months

  7. Change in Physical Function - 6 Minute Walk

    Distance walked (ft) during 6 minute walk test

    Measured: Baseline to 6 weeks

  8. Change in Physical Function - 6 Minute Walk

    Distance walked (ft) during 6 minute walk test

    Measured: Baseline to 6 months

  9. Change in Physical Function - 6 Minute Walk

    Distance walked (ft) during 6 minute walk test

    Measured: Baseline to 12 months

Secondary outcomes (12)
  1. Change in Physical Limitations

    Health Assessment Questionnaire (HAQ) - Total score ranging from 0-3, with a higher score indicating more impairment or disability

    Measured: Baseline to 6 weeks

  2. Change in Physical Limitations

    Health Assessment Questionnaire (HAQ) - Total score ranging from 0-3, with a higher score indicating more impairment or disability

    Measured: Baseline to 6 months

  3. Change in Physical Limitations

    Health Assessment Questionnaire (HAQ) - Total score ranging from 0-3, with a higher score indicating more impairment or disability

    Measured: Baseline to 12 months

  4. Change in Physical Activity

    total moderate and vigorous intensity physical activity (>=2020 cpm) measured by Actigraph GT3x Link activity monitors

    Measured: Baseline to 6 weeks

  5. Change in Physical Activity

    total moderate and vigorous intensity physical activity (>=2020 cpm) measured by Actigraph GT3x Link activity monitors

    Measured: Baseline to 6 months

  6. Change in Physical Activity

    total moderate and vigorous intensity physical activity (>=2020 cpm) measured by Actigraph GT3x Link activity monitors

    Measured: Baseline to 12 months

  7. Change in Arthritis Management Self-efficacy

    Confidence to manage symptoms of arthritis assessed by the Arthritis Self-Efficacy Scale. Total score 0-10 with higher scores indicating higher levels of self-efficacy for managing arthritis

    Measured: Baseline to 6 weeks

  8. Change in Arthritis Management Self-efficacy

    Confidence to manage symptoms of arthritis assessed by the Arthritis Self-Efficacy Scale. Total score 0-10 with higher scores indicating higher levels of self-efficacy for managing arthritis

    Measured: Baseline to 6 months

  9. Change in Arthritis Management Self-efficacy

    Confidence to manage symptoms of arthritis assessed by the Arthritis Self-Efficacy Scale. Total score 0-10 with higher scores indicating higher levels of self-efficacy for managing arthritis

    Measured: Baseline to 12 months

  10. Change in Blood Pressure

    Diastolic blood pressure measured in mmHg

    Measured: Baseline to 6 weeks

  11. Change in Blood Pressure

    Diastolic blood pressure measured in mmHg

    Measured: Baseline to 6 months

  12. Change in Blood Pressure

    Diastolic blood pressure measured in mmHg

    Measured: Baseline to 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Mar 2022
  2. Study start1 Apr 2022
  3. Primary completion10 Sep 2024
  4. Study completion10 Sep 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
267 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05289544
Sponsor's protocol ID
Pro00115106
Status last verified
Feb 2026
First submitted
11 Mar 2022
Last updated
6 Mar 2026
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified data will be made available within 30 months of the completion of the project.

Questions about this trial

What is this clinical trial studying?

A study testing Phone-Based Walk With Ease in people with Arthritis and Gout, run by University of South Carolina at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 6 Mar 2026). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Pain (time frame: Baseline to 6 weeks). The study lists 9 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Mar 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in